http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-986346-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a0e90292f2ba83d7878baca3838b8a2 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-36 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-36 |
| filingDate | 1962-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1965-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-986346-A |
| titleOfInvention | The eledone active polypeptide |
| abstract | In a process for the extraction of the Eledone active polypeptide, the posterior salivary glands of Eledone are first extracted with a lower aliphatic alcohol, the alcohol is evaporated, the fats eliminated by a second extraction of an aqueous solution of the residue with petroleum ether, the resulting aqueous layer is concentrated, separated chromatographically and finally lyophilized. In a preferred embodiment the material from the first chromatographic separation over alumina is subjected to a chromatographic purification over a cationic resin. Pharmaceutical compositions contain the Eledone active polypeptide and a therapeutically acceptable carrier, with or without other therapeutic substances. The preparations are in a form suitable for parenteral administration. The polypeptide is an anti-hypertensive agent. |
| priorityDate | 1961-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.